In peritoneal fibrosis, the role of Wnt5a is context dependent: its profibrotic or antifibrotic effects depends on ROR2 expression, with ROR2 silencing reversing the antifibrotic and antiangiogenic activity of Wnt5a [192]. This evidence concerns the gene WNT5A and Peritoneal Fibrosis.